Cronos Group Inc. Announces Third Quarter 2019 Results
November 12, 2019 07:00 ET
|
Cronos Group Inc.
Closed Redwood U.S. Hemp-Based Products Platform and Cronos Fermentation Facility Acquisitions Announced the launch PEACE+™, A New Hemp-Derived U.S. Brand Advanced Operational Readiness of Cronos...
Cronos Group Establishes New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform
August 02, 2019 07:00 ET
|
Cronos Group Inc.
TORONTO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has entered into a definitive agreement to acquire...
MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal
June 19, 2019 06:00 ET
|
MediPharm Labs Corp.
TORONTO, June 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis...
New York City Ichan School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study and “CBD International Consortium” to Develop Treatment of Opioid Addiction
May 22, 2019 09:08 ET
|
MediPharm Labs Corp.
TORONTO, May 22, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid...
MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million
May 10, 2019 07:01 ET
|
MediPharm Labs Corp.
TORONTO, May 10, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
Cronos Group Inc. Announces First Quarter 2019 Results
May 09, 2019 07:00 ET
|
Cronos Group Inc.
Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs, a State-of-the-Art Vaporizer R&D Initiative NatuEra Receives License to...
Cronos Group Inc. Announces Fourth Quarter 2018 and Full Year 2018 Results
March 26, 2019 07:00 ET
|
Cronos Group Inc.
Closed C$2.4 Billion Strategic Growth Investment from Altria Group, Inc. Completed first harvest in Peace Naturals expansion to Building 4 Launched Two Recreational Brands: COVE™ and Spinach™ ...
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.
March 08, 2019 08:30 ET
|
Cronos Group Inc.
Four New Directors Join Cronos Group Board Jerry Barbato Appointed Chief Financial Officer of Cronos Group; William Hilson Appointed Chief Commercial Officer TORONTO, March 08, 2019 (GLOBE...
Cronos Group Inc. Exits Investment in Whistler Medical Marijuana Corporation
March 04, 2019 07:00 ET
|
Cronos Group Inc.
TORONTO, March 04, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), confirmed today that it has sold all of its common shares in the capital...
Cronos Group Inc. to Hold Full Year and Fourth Quarter 2018 Earnings Conference Call
March 01, 2019 12:00 ET
|
Cronos Group Inc.
TORONTO, March 01, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), will announce its financial results and hold its Full Year and Fourth...